Bosutinib Impurity 60
- CAS67669-19-6
- CatalogueRS-B055037
- FormulaC8H7Cl2NO2
- MW220.05
On this page
Product identification
| Product name | Bosutinib Impurity 60 |
|---|---|
| Catalogue No. | RS-B055037 |
| CAS No. | 67669-19-6 |
| Molecular formula | C8H7Cl2NO2 |
| Molecular weight | 220.05 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Bosutinib |
| Storage | 2℃ ~ 8℃ |
| Pack sizes | 25mg, 50mg, 100mg |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-B055037 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Bosutinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-B055037
- Request a quotation for RS-B055037
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Bosutinib
All 55 further standards are listed here — every link is in the page, not loaded later.
-
Bosutinib
BACK ORDERRS-I012067 -
Bosutinib Monohydrate
IN STOCKRS-B055034 -
Bosutinib Impurity I
IN STOCKRS-B055021 -
1-(3,4-dimethoxy-5-nitrophenyl)ethanone
CUSTOM SYNTHESISRS-U004245 -
1-(3-amino-4,5-dimethoxyphenyl)ethan-1-one
IN STOCKRS-U003137 -
2,4-Dichloro-5-methoxyaniline hydrochloride
IN STOCKRS-U051742 -
2-Cyano-N-(2,4-dichlorophenyl)acetamide
IN STOCKRS-I002278 -
2-methoxy-4-nitrophenol
IN STOCKRS-C001058 -
2-Methoxy-5-Nitrophenol
IN STOCKRS-U211NG6 -
2-Methoxy-5-nitrophenyl Acetate
CUSTOM SYNTHESISRS-U053809 -
4-Chloro-6,7-dimethoxyquinoline-3-carbonitrile
CUSTOM SYNTHESISRS-P001898 -
4-Chloro-7-fluoro-6-methoxy-quinoline-3-carbonitrile
BACK ORDERRS-U111684 -
4-Methoxy-3-(3-(4-methylpiperazin-1-yl)propoxy)aniline
IN STOCKRS-U100874 -
5-Acetamido-2-chlorophenol
IN STOCKRS-U089132 -
Bosutinib 4-Hydroxy 7-Chloropropoxy Impurity
IN STOCKRS-B055027 -
Bosutinib Desmethyl Impurity
BACK ORDERRS-B055029 -
Bosutinib Impurity II
BACK ORDERRS-B055022 -
Bosutinib Regio Isomer Impurity
BACK ORDERRS-B055002 -
Methyl 2-amino-4-(3-chloropropoxy)-5-methoxybenzoate
CUSTOM SYNTHESISRS-P140152 -
Methyl 4-(3-chloropropoxy)-5-methoxy-2-nitrobenzoate
IN STOCKRS-D128075 -
N,N'-Diisopropylcarbodiimide
IN STOCKRS-C005100 -
N-(3-Hydroxyphenyl)acetamide
IN STOCKRS-C005095 -
N-(4-Chloro-2-methoxyphenyl)-2-cyanoacetamide
BACK ORDERRS-U096184 -
N-(4-chloro-3-methoxyphenyl)-2-cyanoacetamide
CUSTOM SYNTHESISRS-P025465 -
N-Desmethyl Bosutinib
IN STOCKRS-B055015 -
N-Desmethylpiperazine Hydroxy Bosutinib
BACK ORDERRS-B055039 -
Bosutinib Impurity 5
BACK ORDERRS-B055014 -
Bosutinib Impurity 11
BACK ORDERRS-B055030 -
Bosutinib Impurity 19
CUSTOM SYNTHESISRS-B055001 -
Bosutinib Impurity 22
IN STOCKRS-B055010 -
Bosutinib Impurity 28
IN STOCKRS-B055009 -
Bosutinib Impurity 29
IN STOCKRS-B055024 -
Bosutinib Impurity 30
BACK ORDERRS-B055016 -
Bosutinib Impurity 39
BACK ORDERRS-B055007 -
Bosutinib Impurity 42
IN STOCKRS-B055032 -
Bosutinib Impurity 49
IN STOCKRS-B055004 -
Bosutinib Impurity 51
IN STOCKRS-B055017 -
Bosutinib Impurity 52
IN STOCKRS-B055018 -
Bosutinib Impurity 53
IN STOCKRS-B055019 -
Bosutinib Impurity 54
IN STOCKRS-B055023 -
Bosutinib Impurity 55
CUSTOM SYNTHESISRS-B055025 -
Bosutinib Impurity 56
CUSTOM SYNTHESISRS-B055026 -
Bosutinib Impurity 58
IN STOCKRS-B055033 -
Bosutinib Impurity 59
IN STOCKRS-B055035 -
Bosutinib Impurity 61
IN STOCKRS-B055038 -
Bosutinib Impurity 65
IN STOCKRS-B055003 -
Bosutinib Impurity 66
IN STOCKRS-B055006 -
Bosutinib Impurity 67
BACK ORDERRS-B055008 -
Bosutinib Impurity 68
IN STOCKRS-B055012 -
Bosutinib Impurity 69
IN STOCKRS-B055013 -
Bosutinib Impurity 70
IN STOCKRS-B055020 -
Bosutinib Impurity 71
IN STOCKRS-B055031 -
Bosutinib Impurity 72
IN STOCKRS-B055036 -
Bosutinib Impurity 88
IN STOCKRS-U005250
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.






















































